Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$10.9 million.

  • Lucid Diagnostics' Free Cash Flow fell 733.17% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.2 million, marking a year-over-year increase of 62.3%. This contributed to the annual value of -$44.4 million for FY2024, which is 3449.97% down from last year.
  • Per Lucid Diagnostics' latest filing, its Free Cash Flow stood at -$10.9 million for Q3 2025, which was down 733.17% from -$10.5 million recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Free Cash Flow ranged from a high of -$4.3 million in Q4 2022 and a low of -$15.4 million during Q2 2022
  • For the 4-year period, Lucid Diagnostics' Free Cash Flow averaged around -$9.6 million, with its median value being -$10.2 million (2023).
  • Within the past 5 years, the most significant YoY rise in Lucid Diagnostics' Free Cash Flow was 5473.07% (2023), while the steepest drop was 13846.88% (2023).
  • Lucid Diagnostics' Free Cash Flow (Quarter) stood at -$4.3 million in 2022, then plummeted by 138.47% to -$10.2 million in 2023, then grew by 0.24% to -$10.1 million in 2024, then dropped by 7.81% to -$10.9 million in 2025.
  • Its Free Cash Flow was -$10.9 million in Q3 2025, compared to -$10.5 million in Q2 2025 and -$12.6 million in Q1 2025.